Neuroblastic Tumor — Trials

Neuroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

619 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 501–550 of 619 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01319838	Aflac ST1001 Prolonged Isotretinoin(Aflac ST1001)	withdrawn	Phase 1	0	Emory UniversityOTHER	1	Dec 10, 2013	clinicaltrials
NCT00025428	Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma	completed	Phase 3	100	Societe Internationale d'Oncologie PediatriqueOTHER	12	Dec 4, 2013	clinicaltrials